eCF-309

Modify Date: 2025-08-25 18:57:35

eCF-309 Structure
eCF-309 structure
Common Name eCF-309
CAS Number 2001571-40-8 Molecular Weight 383.404
Density 1.5±0.1 g/cm3 Boiling Point 642.5±65.0 °C at 760 mmHg
Molecular Formula C18H21N7O3 Melting Point N/A
MSDS N/A Flash Point 342.4±34.3 °C

 Use of eCF-309


eCF309 is a potent and highly selective mTOR inhibitor with remarkably low off-target activities (IC50 = 10-15 nM, both in vitro and in cells)[1].

 Names

Name eCF309
Synonym More Synonyms

 eCF-309 Biological Activity

Description eCF309 is a potent and highly selective mTOR inhibitor with remarkably low off-target activities (IC50 = 10-15 nM, both in vitro and in cells)[1].
Related Catalog
References

[1]. Craig Fraser, et al. eCF309: a potent, selective and cell-permeable mTOR inhibitor. Med. Chem. Commun., 2016, 7, 471-477.

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 642.5±65.0 °C at 760 mmHg
Molecular Formula C18H21N7O3
Molecular Weight 383.404
Flash Point 342.4±34.3 °C
Exact Mass 383.170593
LogP 2.31
Appearance of Characters solid
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.727
Storage condition Store at -20℃
Water Solubility Soluble in DMSO

 Synonyms

2-Benzoxazolamine, 5-[4-amino-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-
3-(2-Amino-1,3-benzoxazol-5-yl)-1-(2,2-diethoxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

eCF-309 suppliers

eCF-309 price

Related Compounds: More...
2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester, reaction products with silicic acid (H4SiO4) zirconium(4+) salt (1:1)
100402-80-0
Bicyclo[3.1.1]heptane-3-thiol, 2,6,6-trimethyl-, gold salt, reaction products with 4,4'-dithiobis[morpholine]
100402-52-6
disodium,[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamothioylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate
100063-53-4
sodium,7-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2Z)-2-(6-nitro-2-oxo-4-sulfonaphthalen-1-ylidene)hydrazinyl]naphthalene-2-sulfonic acid,cobalt
100231-59-2
sodium,7-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2Z)-2-(6-nitro-2-oxo-4-sulfonaphthalen-1-ylidene)hydrazinyl]naphthalene-2-sulfonic acid,chromium
100231-60-5
methyl 2-[[[5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-en-2-yl]methylene]amino]benzoate
99688-46-7
tricopper(1+) hydrogen hexakis(cyano-C)ferrate(4-), compound with ethyl o-[6-(ethylamino)-3-(ethylimino)-2,7-dimethyl-3H-xanthen-9-yl]benzoate (1:1)
101033-43-6
Glycine, N-(2-aminoethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, N,N'-bis(C8-18-branched and linear alkyl) derivs., dihydrochlorides
100208-93-3
Aluminum, 2-(1,3-dihydro-1,3-dioxo-2H-inden-2-ylidene)-1,2-dihydro-6,8-quinolinedisulfonate complexes
100402-45-7
2-((Z)-4-((E)-2-methyl-3-phenylallylidene)-2,5-dioxoimidazolidin-1-yl)-N-(3-(trifluoromethyl)phenyl)acetamide
867312-01-4
(Z)-2-(4-((2-amino-4-oxothiazol-5(4H)-ylidene)methyl)-2-methoxyphenoxy)-N-(4-chlorophenyl)acetamide
871496-94-5
(Dinitromethyl)pyridine
62399-57-9
[(1-Cyano-1,2-dimethylpropyl)carbamoyl]methyl 3-(3-chloro-1-benzothiophen-2-yl)prop-2-enoate
871479-76-4
N-(1-cyanocyclohexyl)-2-{[4-(2-fluorophenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-methylacetamide
871317-37-2
Phosphorus(V) sulfide
1262770-44-4
2-(5a-methyl-2-oxo-5a,11b-dihydro-2H,5H-chromeno[4',3':4,5]thiopyrano[2,3-d][1,3]thiazol-3(6H)-yl)-N-[3-(trifluoromethyl)phenyl]acetamide
871496-99-0
[(1-Cyano-1,2-dimethylpropyl)carbamoyl]methyl 2-fluoro-4-methoxybenzoate
871544-73-9
2-[(3-Cyano-4-methylpyridin-2-yl)sulfanyl]acetamide
498580-72-6
6-(3-((Z)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)-2,5-dioxopyrrolidin-1-yl)hexanoic acid
868152-79-8